Investigation of patients’ preferences regarding therapeutic drug monitoring of mycophenolic acid in solid organ transplantation

LIU Shuang; CHEN Hongsheng; GUO Qi; CHENG Yinchu; ZHAO Rongsheng; HOU Xiaofei

doi:10.6039/j.issn.1001-0408.2024.01.16

您当前的位置：

首页 >

文章列表页 >

Investigation of patients’ preferences regarding therapeutic drug monitoring of mycophenolic acid in solid organ transplantation

更新时间：2024-01-11

- Investigation of patients’ preferences regarding therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
- ZHONGGUO YAOFANG Vol. 35, Issue 1, Pages: 90-94(2024)
- 作者机构：
  
  1.北京大学第三医院药剂科，北京　100191
  2.北京大学医学部药品评价中心，北京　100191
  3.北京大学药学院药事管理与临床药学系，北京　100191
  4.北京大学第三医院泌尿外科，北京　100191
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.01.16
  CLC： R969.3;S857.13+4
- Published：15 January 2024，
  
  Received：14 July 2023，
  
  Revised：12 December 2023，
扫描看全文
刘爽,陈鸿圣,郭琦等.实体器官移植受者接受霉酚酸类药物TDM的意愿调查 ^Δ[J].中国药房,2024,35(01):90-94.

LIU Shuang,CHEN Hongsheng,GUO Qi,et al.Investigation of patients’ preferences regarding therapeutic drug monitoring of mycophenolic acid in solid organ transplantation[J].ZHONGGUO YAOFANG,2024,35(01):90-94.
刘爽,陈鸿圣,郭琦等.实体器官移植受者接受霉酚酸类药物TDM的意愿调查 ^Δ[J].中国药房,2024,35(01):90-94. DOI： 10.6039/j.issn.1001-0408.2024.01.16.

LIU Shuang,CHEN Hongsheng,GUO Qi,et al.Investigation of patients’ preferences regarding therapeutic drug monitoring of mycophenolic acid in solid organ transplantation[J].ZHONGGUO YAOFANG,2024,35(01):90-94. DOI： 10.6039/j.issn.1001-0408.2024.01.16.

摘要

目的

调查实体器官移植受者接受霉酚酸类（MPA）药物治疗药物监测（TDM）的意愿，并探究相关影响因素，为相关指南推荐意见形成及临床决策优化提供参考。

方法

采用横断面研究设计法，设计MPA TDM患者意愿调查问卷，选取2022年4月14日至2022年6月27日在北京市两家三级甲等综合医院接受MPA类药物治疗的实体器官移植受者进行调研。采用Likert 5级评分法对患者接受MPA TDM的意愿进行评分，采用Pearson相关分析和二元Logistic回归分析患者接受MPA TDM的意愿影响因素及其相关性，采用非参数检验和

检验对影响患者意愿决策的因素进行排序及一致性分析。

结果

共收集到有效问卷140份，有效回收率为77.35%。140例患者接受MPA TDM的平均意愿得分为（4.01±0.65）分，表明总体意愿值较高；有116例（82.86%）患者表示愿意或非常愿意接受MPA TDM；既往接受过TDM与未接受过TDM患者的意愿得分差异有统计学意义[（4.30±0.53）分 vs. （3.80±0.65）分，

＜0.001]。患者对MPA TDM的了解程度、重视程度与接受意愿呈显著正相关（

＜0.001）。患者决策影响因素排序具有统计学上的一致性（

＜0.001），影响程度由大到小分别为治疗有效性、安全性、舒适程度、经济性及时间成本。

结论

实体器官移植受者对MPA TDM的接受意愿较高，MPA TDM既往就诊经历和对MPA TDM的了解、重视程度为影响患者意愿的主要因素。

Abstract

OBJECTIVE

To investigate the preferences of patients who underwent solid organ transplantation regarding therapeutic drug monitoring （TDM） of mycophenolic acid （MPA） and explore the factors influencing patients’ decision-making process， so as to provide support for the development of individualized medication guidelines for MPA and improvement of clinical decision-making.

METHODS

The cross-sectional study was used to design the questionnaire on the patients’ preferences to accept MPA TDM， and involved patients who underwent solid organ transplantation and received MPA treatment at two tertiary hospitals in Beijing from April 14， 2022， to June 27， 2022. The Likert 5-level scoring method was used to score the patients’ preferences to accept MPA TDM， the influencing factors and their correlation of the patients’ preferences to accept MPA TDM were analyzed by Pearson correlation analysis and binary Logistic regression analysis， and the nonparametric test and chi-square test were used to rank and analyze the consistency of the factors affecting patients’ preference decision.

RESULTS

A total of 140 questionnaires were collected， and the effective recovery rate was 77.35%. The average preference score of 140 patients to receive MPA TDM was （4.01±0.65）， and the overall preference value was high. There were 116 （82.86%） patients agreed or strongly agreed with MPA TDM. Significant differences were observed in preference scores between patients who had previously undergone MPA TDM and those who had never undergone it [（4.30±0.53） scores vs. （3.80±0.65） scores，

＜0.001]. Additionally， patients’ preference scores were significantly influenced by their understanding level and attention level （

＜0.001）. The ranking of factors contributing to decision-making exhibited consistency （

＜0.001）. The factors were ranked in descending order of clinical efficacy， safety， comfortability， economy and time cost.

CONCLUSIONS

The patients who underwent solid organ transplantation hold high preferences towards MPA TDM. The primary factors influencing their decisions are their prior experience， understanding level， and attention level.

关键词

霉酚酸类药物治疗药物监测患者意愿实体器官移植问卷调查

Keywords

therapeutic drug monitoringpatient’s preferencessolid organ transplantationquestionnaire survey

references

NELSON J，ALVEY N，BOWMAN L，et al. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation：endorsed by the American College of Clinical Pharmacy，American Society of Transplantation，and the International Society for Heart and Lung Transplantation[J]. Pharmacotherapy，2022，42（8）：599-633.

LENTINE K L，SMITH J M，MILLER J M，et al. OPTN/SRTR 2021 annual data report：kidney[J]. Am J Transplant，2023，23（2 Suppl 1）：S21-S120.

COLVIN M M，SMITH J M，AHN Y S，et al. OPTN/SRTR 2021 annual data report：heart[J]. Am J Transplant，2023，23（2 Suppl 1）：S300-S378.

KWONG A J，EBEL N H，KIM W R，et al. OPTN/SRTR 2021 annual data report：liver[J]. Am J Transplant，2023，23（2 Suppl 1）：S178-S263.

VALAPOUR M，LEHR C J，SCHLADT D P，et al. OPTN/SRTR 2021 annual data report：lung[J]. Am J Transplant，2023，23（2 Suppl 1）：S379-S442.

BERGAN S，BRUNET M，HESSELINK D A，et al. Personalized therapy for mycophenolate：consensus report by the International Association of Therapeutic Drug Monito- ring and Clinical Toxicology[J]. Ther Drug Monit，2021，43（2）：150-200.

DJULBEGOVIC B，GUYATT G H. Progress in evidence-based medicine：a quarter century on[J]. Lancet，2017，390（10092）：415-423.

Institute of Medicine （US） Committee on Standards for Developing Trustworthy Clinical Practice Guidelines，GRAHAM R，MANCHER M，et al. Clinical practice guidelines we can trust[M]. Washington （DC）：National Academies Press （US），2011：1-290.

BAI F，LING J，ESOIMEME G，et al. A systematic review of questionnaires about patient’s values and prefe- rences in clinical practice guidelines[J]. Patient Prefer Adherence，2018，12：2309-2323.

BASTEMEIJER C M，VOOGT L，VAN EWIJK J P，et al. What do patient values and preferences mean? A taxo- nomy based on a systematic review of qualitative papers[J]. Patient Educ Couns，2017，100（5）：871-881.

RONG Y，PATEL V，KIANG T K L. Recent lessons learned from population pharmacokinetic studies of mycophenolic acid：physiological，genomic，and drug interactions leading to the prediction of drug effects[J]. Expert Opin Drug Metab Toxicol，2021，17（12）：1369-1406.

刘爽，张恩瑶，宋再伟，等. 霉酚酸治疗药物监测必要性的系统评价与Meta分析[J]. 中国医院药学杂志，2021，41（5）：495-501，511.

LIU S，ZHANG E Y，SONG Z W，et al. Systematic review and meta-analysis on the necessity of therapeutic drug monitoring of mycophenolic acid[J]. Chin J Hosp Pharm，2021，41（5）：495-501，511.

DOWNING H J，PIRMOHAMED M，BERESFORD M W，et al. Paediatric use of mycophenolate mofetil[J]. Br J Clin Pharmacol，2013，75（1）：45-59.

CAI M Y，ZHOU L，GAO D H，et al. A national survey of individualized pharmaceutical care practice in Chinese hospitals in 2019[J]. Front Pharmacol，2023，14：1022134.

YIN T，LIANG H Y，HUANG Q，et al. A survey of therapeutic drug monitoring status in China[J]. Ther Drug Monit，2023，45（2）：151-158.

刘爽，张恩瑶，易湛苗，等. 中国霉酚酸治疗药物监测的现状分析[J]. 中国临床药理学杂志，2021，37（3）：308-311.

LIU S，ZHANG E Y，YI Z M，et al. Analysis for the current status of mycophenolic acid therapeutic drug monito- ring in China[J]. Chin J Clin Pharmacol，2021，37（3）：308-311.

ZENG L N，YI Q S，HUANG L，et al. The guideline for therapeutic drug monitoring guidelines development[J]. J Evid Based Med，2022，15（3）：272-283.

SERRANO-AGUILAR P，TRUJILLO-MARTIN M D E L M，PÉREZ DE LA ROSA A，et al. Patient participation in a clinical guideline development for systemic lupus erythematosus[J]. Patient Educ Couns，2015，98（9）：1156-1163.

YE Z K，REINTAM BLASER A，LYTVYN L，et al. Gastrointestinal bleeding prophylaxis for critically ill patients：a clinical practice guideline[J]. BMJ，2020，368：16722.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on the present situation of narcotic drugs equipment and management in 251 primary healthcare institutions from Qiandongnan prefecture

临床药理学中以问题为基础的教学模式的探索与实践

社区药学服务对高血压患者认知行为的影响的调查分析

Evaluation of the rationality and feasibility of the grouping method for centralized procurement of insulin drugs in Wuhan based on the results of questionnaire survey among endocrinology physicians

Investigation and Analysis of the Implementation Status and Effect of Electronic Prescription and Remote Pharma- ceutical Care in Social Pharmacy from the Perspective of Consumers

Related Author

HAN Minzhen

ZHANG Zhenzhu

XIA Jie

LIU Yang

HU Hanshuai

WANG Jinxingyi

龙锐张成志朱深银周远大邱峰陈庆宪李娟

邹殿明洪惠

Related Institution

Dept. of Pharmacy， the Second Affiliated Hospital of Guizhou Medical University， Guizhou Kaili

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰